Investigación

Leucemia y hemopatías pediátricas

Buscador de publicaciones

Publicaciones

  • Río P, Zubicaray J, Navarro S, Gálvez E, Sánchez-Domínguez R, Nicoletti E, Sebastián E, Rothe M, Pujol R, Bogliolo M, John-Neek P, Bastone AL, Schambach A, Wang W, Schmidt M, Larcher L, Segovia JC, Yáñez RM, Alberquilla O, Díez B, Fernández-García M, García-García L, Ramírez M, Galy A, Lefrere F, Cavazzana M, Leblanc T, García de Andoin N, López-Almaraz R, Català-Temprano A, Barquinero J, Rodríguez-Perales S, Rao G, Surrallés J, Soulier J, Díaz-de-Heredia C, Schwartz JD, Sevilla J and Bueren JA.

    Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.

    Lancet . 404(10471): 2584-2592. Nº de citas: 2

    [doi:10.1016/S0140-6736(24)01880-4]

  • Falgàs A, Lázaro-Gorines R, Zanetti SR, Rubio-Pérez L, Martinez-Moreno A, Vinyoles M, Guerrero-Murillo M, Fernandez-Fuentes N, Roca-Ho H, Tirado N, Panisello C, Velasco-Hernandez T, Mayado A, Pérez-Pons A, Genesca E, Ribera JM, Ribera J, Camós-Guijosa M, Ramírez-Orellana M, Anguita E, Ballerini P, Fuster JL, Juan-Otero M, González-Navarro EAA, Locatelli F, Stam RWW, Querol S, Velasco P, Ortiz-Maldonado V, Martínez-Cibrian N, Delgado J, Orfao A, Alvarez-Vallina L, Bueno C and Menendez P.

    A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

    Blood . 145(22): 2599-2613.

    [doi:10.1182/blood.2024025440]

  • Berrueco R, Soto I, Bastida JM, Calvo Villas JM, de Cos C, Haya S, García FS and Mateo Arranz J.

    Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus.

    Journal of Clinical Medicine . 14(10): .

    [doi:10.3390/jcm14103300]

  • Vicente-Garces C, Fernandez-Isern G, Esperanza-Cebollada E, Richarte M, Crespo-Carrasco A, Montesdeoca S, Isola I, Sarrate E, Cuatrecasas E, Rives-Solà S, Dapena JL, Camós-Guijosa M and Vega-García N.

    RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.

    BRITISH JOURNAL OF HAEMATOLOGY . 206(5): 1355-1365.

    [doi:10.1111/bjh.20056]

  • Mato S, Carità L, Colmenero A, Andrés M, Balagué O, Andión M, Astigarraga I, Celis-Passini V, Mendoza C, Guerra-García P, Valero L, Galera A, Tallón M, Pol M, Castrejón-de-Anta N, Frauenfeld L, Garcia N, Campo E, Salaverria I and Verdú-Amorós J.

    Comprehensive analysis of relapsed-refractory mature B-cell non-Hodgkin lymphoma in children and adolescents.

    BRITISH JOURNAL OF HAEMATOLOGY . 206(5): 1390-1396.

    [doi:10.1111/bjh.20012]

  • Velasco Puyo P, Christou S, Campisi S, Rodríguez-Sánchez MA, Reidel S, Perez-Hoyo S, Mota M, Savvidou I, Rekleiti A, Salvo A, Voi V, Ferrero GB, Mandrile G, Gaglioti CM, Cela E, Ponce-Salas B, Bardón-Cancho EJ, Flevari P, Voskaridou-Dimoula E, Nur E, Biemond BJ, Delaporta P, Beneitez-Pastor D, Collado Gimbert A, Spasiano A, Besse-Hammer T, Lafiatis IG, Dedeken L, Raso S, Ruiz-Llobet A, Bagnato S, Labarque V, Glenthøj A, Ruffo GB, Guerzoni ME, Hafraoui K, Pistoia L, Rosso R, Tagliaferri L, Gonzalez-Urdiales P, Benghiat FS, de Montalembert M, Teles MJ, Vanderfaeillie A, Bertoni E, Cuzzubbo D, Ferreira T, Saunders CJ, Stiakaki E, Van de Velde AL, Diamantidis MD, Kerkhoffs JH, Oliveira MI, Quota A, Russo R, Van Damme A, Argüello Marina M, Lorite Reggiori M, Rijneveld AW, Rodríguez Gallego A, Colombatti R, Iolascon A, Taher A, Gulbis B, Roy NBA and Mañú-Pereira MDM.

    COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet

    ORPHANET JOURNAL OF RARE DISEASES . 20(1): 183-183.

    [doi:10.1186/s13023-025-03683-7]

  • Del Castillo Velilla I, Solsona M, Sarrate E and Felipe-Villalobos A.

    Craniofacial lession as a presentation of idiopathic purpura fulminans.

    anales de pediatria . 102(4): 503765-503765.

    [doi:10.1016/j.anpede.2025.503765]

  • Galán-Gómez V, González-Martínez B, Alonso-Saladrigues A, Rives-Solà S, Herrero B, Kwon M, Sánchez-Pina J, Minguillón J, Martínez-Romera I, Mirones Aguilar I, Mestre-Durán C, Casado G, Sánchez-Martín M, Echecopar C, González-Pérez C, León-Triana O, Aguirre-Portolés C, Molinos-Quintana Á, Barba P, Balsalobre P and Pérez-Martínez A.

    Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults.

    Experimental Hematology and Oncology . 14(1): 49-49. Nº de citas: 1

    [doi:10.1186/s40164-025-00638-3]

  • Pearson ADJ, Rossig C, Mackall CL, Shah NN, Baruchel A, Daems S, Anderson J, Biondi A, Bird N, Bodmer N, Brivio E, Buechner J, Calkoen FG, Cooper T, de Rojas T, Fox E, Gardner R, Ghorashian S, Heenen D, Ifversen M, Jacoby E, Juan-Otero M, Knox L, Komanduri K, Larghero J, Locatelli F, Ludwinski D, Majzner RG, McDonough J, Minard-Colin V, Nysom K, Pappo A, Park JR, Qasim W, Quintarelli C, Rives-Solà S, Rouce RH, Scobie N, Seitz C, Tasian SK, Weigel B, Weiner S, Zwaan CM and Vassal G.

    New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.

    LANCET ONCOLOGY . 26(4): 214-224.

    [doi:10.1016/S1470-2045(24)00736-8]

  • Marina Caballero Bellón, Bobillo-Perez S, Català-Temprano A, Alonso-Saladrigues A, Valls-Lafon A, Rives-Solà S and Jordán-García I.

    Role of procalcitonin, C-reactive protein and ferritin in cytokine release syndrome after CAR T-cell therapy in children and young adults

    Biomarkers . 30(2): 115-122. Nº de citas: 1

    [doi:10.1080/1354750X.2025.2454471]